Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Navidea establishes Macrophage Therapeutics to develop drugs targeting activated macrophages

Dec. 12, 2014

FDA approves Quidel's AmpliVue Bordetella Assay

Dec. 12, 2014

Nihon Medi-Physics patents Abeta imaging agents

Dec. 12, 2014

Scientists develop paper-based, cell-free, stable, synthetic gene network arrays

Dec. 9, 2014

Cepheid receives FDA clearance to market norovirus diagnostic

Dec. 3, 2014

Thermo Fisher Scientific and Samsung Electronics initiate POC diagnostic collaboration

Nov. 28, 2014

Diaxonhit initiates clinical study of Dx15 molecular test for thyroid cancer

Nov. 21, 2014

Protagen and Qiagen to develop protein-based companion diagnostics for autoimmune drugs

Nov. 20, 2014

ProACT study evaluates procalcitonin levels in patients with lung infections

Nov. 18, 2014

Asuragen launches Quantidex DNA Assay

Nov. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...